A Study to Assess the Safety, Tolerability, and Pharmacology of Darifenacin in Patients With ALS

Conditions: Amyotrophic Lateral Sclerosis Interventions: Drug: Darifenacin 7.5 MG Extended Release Oral Tablet; Drug: Placebo Sponsors: McGill University; Universit é de Montréal Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials